Aptamer 学术简报 — cancer — 2026-06-13
自动生成 by RBTX Aptamer Tracker v0.1。 子主题 cancer:近 14 天 60 篇命中(aptamer 池 227 篇)。
评分公式:composite = 0.45×log(IF) + 0.35×log(cites_velocity) + 0.10×social + 0.10×recency_bonus;满分 100。
#1 [14.3] Multifunctional DNA Nanoplatform Based on CuInS/ZnS QDs and Rolling Circle Amplification for Synergistic PTT/CDT/CT of Multidrug Resistant Cancer Cells.
- Journal: ACS applied materials & interfaces (IF 9.5)
- Date: 2026-06-12 · Citations: 0
- Authors: Ding K, Zhou T, Weng T et al. (9 authors)
- DOI: 10.1021/acsami.6c06610 · PMID: 42281380
- Score components: IF 10.2 · recency 96.7
Synergistic therapy holds significant potential in cancer diagnosis and treatment, yet faces substantial challenges such as nonspecific drug release and tumor multidrug resistance (MDR). Herein, we report a self-assembled DNA nanoplatform (ZCIS QDs@RD) based on CuInS/ZnS QDs (ZCIS QDs) and rolling circle amplification (RCA) for synergistic photo...
#2 [14.1] Engineered dual-fluorescence functional nucleic acid-based CRISPR/Cas12a biosensor for label-free ratiometric detection of site-specific DNA methylation.
- Journal: Synthetic and systems biotechnology (IF ?)
- Date: 2026-06-01 · Citations: 3 · 0.25 cites/day
- Authors: Tian W, Yu S, Zhang K et al. (6 authors)
- DOI: 10.1016/j.synbio.2025.11.003 · PMID: 41321596
- Score components: velocity 23.2 · recency 60.0
The CRISPR/Cas12a system holds significant promise for biomedical applications. Nevertheless, the commonly used reporter, fluorophore-quencher-labeled substrates, is hindered by labor-intensive synthesis procedures and high costs, while also relying on a single-photon method and being vulnerable to environmental interference. Herein, a label-fre...
#3 [14.0] A Photosensitizer-Intercalated Programmable DNA System for Enhanced Photoimmunotherapy via Tumor Microenvironment Remodeling.
- Journal: Advanced healthcare materials (IF 10.0)
- Date: 2026-06-11 · Citations: 0
- Authors: Yang J, Cui X, Zhang D et al. (7 authors)
- DOI: 10.1002/adhm.71350 · PMID: 42277631
- Score components: IF 10.4 · recency 93.3
Photoimmunotherapy (PIT) has emerged as a minimally invasive therapeutic modality for cancer, offering high spatial precision and favorable therapeutic outcomes. However, the aggregation-caused quenching (ACQ) of photosensitizers and the hypoxic tumor microenvironment (TME) limit its overall efficacy. Herein, a DNA tetrahedron-based nanoplatform...
#4 [13.9] Programmable Chimeric Antigen Receptor T Cell Circuits With DNA Computing for Precision Tumor Therapy.
- Journal: Angewandte Chemie (International ed. in English) (IF 16.1)
- Date: 2026-06-08 · Citations: 0
- Authors: Zhang M, Zhang Q, Yu X et al. (9 authors)
- DOI: 10.1002/anie.9420497 · PMID: 42051201
- Score components: IF 12.3 · recency 83.3
Chimeric antigen receptor (CAR) T cells, a promising cancer therapeutics, still face challenges in safety and efficacy due to the incapability to precisely regulate T cell activation. Here we develop a DNA-logic CAR (DL-CAR) system that enables programmable targeting and precise ablation of tumors with specific antigen combination patterns. The ...
#5 [13.8] DNA hydrogel-delivered hypoxic exosomes alleviate radiation-induced skin injury by stabilizing AKT.
- Journal: Journal of nanobiotechnology (IF 10.6)
- Date: 2026-06-10 · Citations: 0
- Authors: Yin Q, Deng S, Liu Y et al. (13 authors)
- DOI: 10.1186/s12951-026-04653-2 · PMID: 42271440
- Score components: IF 10.6 · recency 90.0
BACKGROUND: Radiation-induced skin injury (RISI) is a common and refractory complication during tumor radiotherapy, characterized by radiation stress-induced impairment of keratinocyte viability and regenerative signaling, ultimately leading to delayed skin repair. Recently, hypoxia-preconditioned adipose-derived stem cell-derived exosomes (A-He...
#6 [13.6] Protamine-modified CuAu nanocarrier enhances aptamer-mediated synergistic therapy for breast cancer.
- Journal: International journal of biological macromolecules (IF 7.7)
- Date: 2026-06-11 · Citations: 0
- Authors: Huo X, Wang X, Ding K et al. (8 authors)
- DOI: 10.1016/j.ijbiomac.2026.153013 · PMID: 42276467
- Score components: IF 9.4 · recency 93.3
Although aptamers held promise for precision cancer therapy, their physiological instability and the lack of multifunctional delivery platforms that enabled synergistic therapeutic effects remained key challenges. In this study, a nanocarrier based on protamine-modified CuAu bimetallic nanozyme was constructed to co-load AT11 aptamer and Doxorub...
#7 [13.3] Functionalized Fluorescent Nanodiamonds Reveal Therapeutic Protein Clearance Through ENDOTAC Linked to AUTOTAC
- Journal: Advanced Healthcare Materials (IF 10.0)
- Date: 2026-06-09 · Citations: 0
- Authors: Yi‐Cheng Lin, Yen-Her Lai, Jiun-Yu Pang et al. (14 authors)
- DOI: 10.1002/adhm.202505913 · PMID: 42266017
- Score components: IF 10.4 · recency 86.7
Targeted protein degradation has emerged as a transformative therapeutic modality in cancer therapy, enabling the elimination of undruggable proteins and overcoming conventional small-molecule resistance. Therapeutic approaches such as endocytosis-targeting chimera (ENDOTAC) and autophagy-targeting chimera (AUTOTAC) facilitate undruggable protei...
#8 [12.8] An electrochemical biosensing platform based on α‑iron trioxide/ferriferrous oxide magnetic nanocomposites for early diagnosis of hepatocellular carcinoma.
- Journal: Bioelectrochemistry (Amsterdam, Netherlands) (IF ?)
- Date: 2026-06-01 · Citations: 2 · 0.17 cites/day
- Authors: Zhang H, Ouyang H, Zhou Z et al. (6 authors)
- DOI: 10.1016/j.bioelechem.2025.109203 · PMID: 41406518
- Score components: velocity 19.4 · recency 60.0
The detection of biologically active proteins in complex biological matrices such as serum remains challenging. To enhance the sensitivity and accuracy of detecting the hepatocellular carcinoma biomarker stress-induced phosphoprotein 1 (STIP1), we proposed a label-free "Turn-off" electrochemical aptamer-based biosensing platform without requirin...
#9 [12.2] Tracing Tumor-Derived Extracellular Vesicle Matrix Metalloproteinase 14 Using Dual-Target Orthogonal Barcoding-Based Microscale Thermophoretic Assays.
- Journal: ACS nano (IF 15.8)
- Date: 2026-06-03 · Citations: 0
- Authors: Chen A, Wang R, Zou Y et al. (11 authors)
- DOI: 10.1021/acsnano.6c07750 · PMID: 42234976
- Score components: IF 12.2 · recency 66.7
Longitudinal monitoring of tumor progression and metastasis provides significant benefits to improve the treatment outcome of breast cancer. Matrix metalloproteinase 14 (MMP14) on extracellular vesicles (EVs) is highly relevant to tumor invasiveness, yet the sensitivity and specificity of detection are hindered by tremendous amounts of normal EV...
#10 [12.1] Electrochemically activated DNA circuit for the amplified and accurate biosensing of cancer cells.
- Journal: Biosensors & bioelectronics (IF 10.7)
- Date: 2026-06-05 · Citations: 0
- Authors: Cao Y, Pan Y, Huang Z et al. (8 authors)
- DOI: 10.1016/j.bios.2026.118907 · PMID: 42259088
- Score components: IF 10.7 · recency 73.3
The detection of cancer cells not only facilitates the early diagnosis of cancers but also provides valuable support for formulating personalized treatment plans for patients. In this work, we develop a new aptamer-based electrochemical biosensing method for cancer cell detection, employing an electrochemically activated DNA circuit as a signal ...
Methodology
- 数据源:PubMed (esearch + esummary), OpenAlex (concept C2776201186 + DOI 反查 citations), bioRxiv (preprints)
- 去重:按 DOI 跨源合并
- IF:硬编码 top 50 期刊 JCR 2024 IF(
config.JOURNAL_IF) - Citation velocity:OpenAlex
cited_by_count/ 发表天数 - Social:Reddit r/science + r/biotech + HN(DOI/title 关键词搜)
- 窗口:近 14 天发表;超出 30 天 recency_bonus = 0
- 每天:建议 8-9am 跑
python run.py collect && python run.py score && python run.py report